24 Stock Top Picks and 3 ETF (Jan 11-17)
This week there were 24 Top Picks and 3 ETF in a wide range of industries: ETF, Financials, Technology, Healtcare, Consumer, Basic Materials, Industrials, Energy, Telecommunications and Utilities.
Here are this week’s Top Picks as selected by: David Cockfield, Fabrice Taylor, James Hodgins, Brooke Thackray, Michael Sprung, Ryan Bushell, Jaime Carrasco, Robert McWhirte, Michael Simpson and David Driscoll.
If you have a growth part of your portfolio, it should be in the TFSA. You want maximum growth in TFSA so he would not recommend it for these accounts.
Doesn't generally like low vols because the performance tends to be lacklustre. But this one has been doing quite well. You could consider this one.
A lot of put-buying last Friday and today we're seeing those returns. The first trade he saw today were 30,000 IWM puts. IWM covers the Russell 2000, down 4% today as of noon.
Building back a position in the banks, but not overweight. Great exposure to US, great performer. Still some concern of a recession. Yield of 4% that grows 7-8% a year is attractive.
Its international exposure makes it stand out, but this faces a strong USD. Their rivals are more aggressive in expanding in the U.S. BNS didn't make the smartest bet by emphasizing Latin America who BNS has stumbled. He no longer owns this.
Financials as a group are neutral. Yield is 5%, growing around 10%, very attractive. Rates are slowly going to work their way higher over several years. Will benefit from an improving equity market. One you can put away and get a good total return.
Strange fee structure. Be cautious in that India has little corporate governance. Better way to participate in EM is to own some of the great global companies, like Unilever, that benefit from the growth there and follow expected corporate governance.
He has been investing in this for almost three years now. They received Health Canada approval for a new brain stimulation medical device last fall. They are awaiting FDA approval in the US. It magnifies the result of physio-therapy for the brain and the technology is safe. It is a billion dollar business if it…
The company supplies hospitals with medical supplies. 90% of their products are disposable. They have been hurt from COVID as operations have been delayed and it looks that may continue. In a normalized time, they are well situated for an aging population, which should translate into double-digits earnings growth going forward.
He recommends it, but has had a rough year. It did good business during Covid, mostly in Covid testing. But this created tough comparisons. Recently, it reported an excellent quarter. DHR reported a big top and bottom line beat and gave robust full-year and current-quarter guidance. Share have been rallying ever since. They are genuises…
They own a series of food distribution businesses. It appears they are not making any money from them. It appears to be a scale problem.
Wait until they report on Wednesday, then do some buying. They make out like a bandit only when normal retailers need to dump their excess inventory which is happening now.
Question is, how do they grow? But this is outweighed by value and extraordinary free cashflow. Good news is their spectacular job with their global portfolio. Current dividend yield is the best and most sustainable in Canadian gold mining.
Just delivered a beat in their quarterly report last week, but the stock actually got hit. Days later, Bank of America upgraded EMN and the stock rebounded. He recommended this in June because there's a long-term shortage of the chemicals they supply. Also, EMN has developed a technology that makes recycled plastic a lot more…
Agriculture sector held up the best of all commodities. Shortages in fertilizer. Seasonality could come into play, but there's good visibility into next year. Stock bottomed nicely, has outperformed since the market bottom, and looks to be resilient. Great way to participate in an undersupplied market, with no new supply coming on soon from eastern…
To manage risk, he sets up his portfolios starting with the biggest, which is FNV. More diversified than OR. He also owns OSK proper.
It is a play on the re-opening trade. There are opportunities for long term investors but you have to be confident that we'll get through a recession. Air Canada is at a very attractive valuation. October/November should see improvement in the airlines. Buy in small quantities.
(A Top Pick Jan 17/19, Up 68%) This is artificial intelligence that is replacing people in call centres. These are insurance and financial call centres. He expects there to still be a long runway to come. This trades in France.
(A Top Pick Jan 17/19, Down 7%) He blames the CFO for the loss. They were signing contracts that were not compliant and their guidance was off. Even though the stock is down, if they have earnings of 3.20 per share range, the stock is fully valued. If they make 4.20 next year, the stock…
They're in northeast BC where Tourmaline is consolidating land and assets, near LXE. So, LXE will become topical. LXE has reached an inflection point after acquiring a lot of land and pushed the Montney play to the northeast. Now, they need a lot of capital to move to full development. They're talking to potential buyers,…
A core holding for yield seekers. Very good company. They're less indebted than Enbridge. The dividend will continue to rise. You can own just one or two pipelines, and not all of them. Not a lot of growth. Buy for the dividend.
Very good company that is trading at cheap price. Trading at ~1x cash flow per share. Very well exposed to European gas prices. Share price be not be as cheap as it appears given European gas prices may fall drastically.
Series of higher lows, making the lows more durable. Not his typical holding, but the catalyst with Shaw is significant. Will probably work out. He'd wait to see the chart develop. Telcos have been difficult, but getting better. Start with a partial position, and add as the chart shows strength.
Tremendous political support for renewable energy. Most customers are in Europe, seeing exceedingly high power prices. Can reset contract pricing. Due to report today. Recently took out March highs. Potential rising margins. Strong competitive position. Yield is 2.73%. (Analysts’ price target is $46.28)
Allan Tong’s Discover Picks Rising rates will add to their debt service costs, though all utilities carry a lot of debt. Emera’s debt-to-capital of 61%. is in-line with the sector. The company can charge more to their customers. Over the past year, EMA has gradually climbed from $55 to $64 a share and given a…
As part of his barbell approach, he has pretty good exposure to staples and utilities, and dividend growth in particular. Great record of growing dividend. Yield of 3.5%, growing at 6-7% a year. Won't shoot the lights out if there's a strong market from here, but it will be a steady performer.